Results 141 to 150 of about 158,299 (299)

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink   +21 more
wiley   +1 more source

Access in all areas? A round-up of developments in market access and health technology assessment: part 14

open access: yesJournal of Comparative Effectiveness Research
In this update we examine the selection of 15 drugs for the third cycle of Medicare price negotiations under the Inflation Reduction Act and analyze emerging evidence of the Most-Favored-Nation impact on global pharmaceutical access, including launch ...
Sreeram V Ramagopalan   +1 more
doaj   +1 more source

Testimonio de la historiadora Ema Cibotti sobre su libro Queridos enemigos

open access: yes, 2014
En diálogo telefónico con el programa Por la radio, con la periodista Virginia Vénere, la historiadora Ema Cibotti, especialista en Historia Social Argentina, se refiere a su más reciente libro Queridos enemigos.
Cibotti, Ema, Vénere, Virginia
core  

New therapeutic options for metabolic‐associated steatotic liver disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

EMA podcast transcript: getting started with small-scale EMA

open access: yes, 2016
The text transcript for a Jisc podcast on getting started with the electronic management of assessment (EMA).
Ferrell, Gill
core  

Paediatric clonidine medication errors: Findings from a multicentre French study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to describe the characteristics of medication errors involving clonidine in paediatric patients and reported to French Network of Pharmacovigilance and Poison Control Centres. Methods This retrospective observational study analysed clonidine‐related medication errors reported between 1985 and June 2024 in patients under 12 years ...
Eve‐Marie Thillard   +8 more
wiley   +1 more source

Testimonio de la historiadora Ema Cibotti sobre su libro Queridos enemigos

open access: yes, 2006
En diálogo telefónico con el programa Por la radio, con la periodista Virginia Vénere, la historiadora Ema Cibotti, especialista en Historia Social Argentina, se refiere a su más reciente libro Queridos enemigos.
Cibotti, Ema, Vénere, Virginia
core  

Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Safe prescribing and effective medication review during acute hospitalization depends on accurate information about liver and kidney function because these organs are responsible for the elimination of most medications. While estimates for kidney function are widely used, comparable markers of hepatic drug‐metabolizing capacity are not routinely ...
Louise Westberg Strejby Christensen   +17 more
wiley   +1 more source

The EMAS Archiving Program [PDF]

open access: yesThe Computer Journal, 1975
openaire   +1 more source

EMA – Publication of the EMA’s Annual activity report for 2024

open access: yes
The consolidated Annual activity report provides an overview of the activities and achievements of the European Medicines Agency (hereinafter EMA or the Agency) in 2024. The EMA Annual activity report 2024 is a report of the EMA Executive Director. It is a key component of the strategic planning and programming cycle and the basis upon which the EMA ...
openaire   +1 more source

Home - About - Disclaimer - Privacy